Healthcare

Nigeria has the largest consumer base in Sub-Saharan region. A larger part of the population living in urban areas is a favorable indicator for market entry. Robust growth of around 7% for the past decade is threatened by macroeconomic challenges, particularly exchange-rate volatility and falling global oil prices that impact public-sector spending...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the African healthcare industry in 2017. The markets covered include pharmaceuticals and biotechnology, in-vitro diagnostics, medical devices, medical imaging and healthcare IT. The analysis captures the impact of trends that are expected ...

27 Sep 2017  |  Africa  |  Market Research

East African Pharmaceutical Market, Forecast to 2021

Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

Infographics

×

Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...

The study analyses the Kenyan and Rwandan health care landscape, market outlook, and investment and growth opportunities. It also discusses the drivers and restraints and the dynamics of the hospital construction market and concludes by providing a list of upcoming projects and strategic recommendations for the markets in Kenya and Rwanda. The res...